Compounds > 3',5'-dichloromethotrexate
Page last updated: 2024-08-21

3',5'-dichloromethotrexate and Carcinoma, Anaplastic

3',5'-dichloromethotrexate has been researched along with Carcinoma, Anaplastic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BOOTH, BA; SARTORELLI, AC1
Doria, MI; DuBrow, RA; Faintuch, J; Levin, B; Riddell, RH; Shepard, KV1
Natale, RB; Roberts, JA; Wheeler, RH1

Other Studies

3 other study(ies) available for 3',5'-dichloromethotrexate and Carcinoma, Anaplastic

ArticleYear
Comparative effects of amethopterin and 3',5'-dichloroamethopterin in sensitive and resistant sublines of the Ehrlich carcinoma.
    Cancer research, 1962, Volume: 22

    Topics: Animals; Carcinoma; Folic Acid Antagonists; Methotrexate; Neoplasms, Experimental

1962
Hepatitis in patients receiving intraarterial chemotherapy for metastatic colorectal carcinoma.
    American journal of clinical oncology, 1987, Volume: 10, Issue:1

    Topics: Bilirubin; Carcinoma; Chemical and Drug Induced Liver Injury; Colonic Neoplasms; Female; Floxuridine; Hepatic Artery; Hepatitis; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Rectal Neoplasms; Transaminases

1987
Cisplatin and dichloromethotrexate: a pharmacologically rational combination.
    NCI monographs : a publication of the National Cancer Institute, 1987, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Evaluation; Female; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Methotrexate; Middle Aged; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms

1987